Opinion

Video

Comparing Venetoclax-Ibrutinib, Venetoclax-Obinutuzumab, and BTKi Options

Panelists discuss the role of ven-ibr in patient populations.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Video content above is prompted by the following:

    • What is role of ven-ibr in these patient populations?
    • When may you opt for this approach over other time-limited therapy options (ven-obi) or continuous BTKi therapy?